Aim: to optimize the preparation of the ginger oleoresin alginate-chitosan microcapsules and to study its stability.
目的：优化姜油树脂海藻酸钠-壳聚糖微囊的制备工艺，并对其稳定性进行考察。
OBJECTIVE To prepare ketorolac tromethamine(KT)alginate-chitosan microcapsules, and to investigated the behavior of KT microcapsules in vitro.
目的制备酮咯酸氨丁三醇的海藻酸钠-壳聚糖微囊，对其体外释药特性进行考察。
Methods: 1. Electrostatic droplet technique was adopted to fabricate ACA microcapsules with chitosan of different molecular weights and in different membrane-forming time.
方法：1、采用静电液滴法制备微胶囊，并选用不同分子量的壳聚糖，在不同成膜时间下制备不同的ACA微胶囊。
OBJECTIVE: to prepare aspirin chitosan-sodium alginate microcapsules (ACSPM) and to investigate its optimal formula and releasing mechanism.
目的：制备阿司匹林壳聚糖-海藻酸钠微囊(ACSPM)，并研究其处方优化与释药机制。
By the coating with chitosan on the surface of sodium alginate microcapsules, the BSA release from microcapsules is extended from several hours to more than half a month.
通过壳聚糖在海藻酸钠微囊表面的复合，牛血清白蛋白从微囊中的持续释放时间从几个小时延长到半个月以上。
Methods Breviscapine chitosan-alginate microcapsules were prepared by coacervation technology.
方法采用复凝聚法制备了灯盏花素壳聚糖-海藻酸钠微囊。
Objective To investigate the preparation technology and the drug release mechanism of Breviscapine chitosan-alginate microcapsules.
目的考察灯盏花素壳聚糖- 海藻酸钠微囊的制备工艺和释药机制。
Objective To investigate the preparation technology and the drug release mechanism of Breviscapine chitosan-alginate microcapsules.
目的考察灯盏花素壳聚糖- 海藻酸钠微囊的制备工艺和释药机制。
应用推荐